Results 201 to 210 of about 88,403 (224)

Interaction between 24 h Urinary Free Cortisol and Obesity in Hypertension-Mediated Organ Damage in Patients with Untreated Hypertension. [PDF]

Rev Cardiovasc Med
Cao GZ, Huang JY, Lin QS, Chen C, Wu M, Wang R, Ng MY, Yiu KH, Xiu JC.   +8 more
europepmc   +1 more source

Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta-2-Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression. [PDF]

J Clin Lab Anal
Cerezo I, Cancho B, Rodriguez Sabillon JA, Jorge A, Alvarez Lopez A, Valladares J, Lopez Gomez J, Romero J, Robles NR.   +8 more
europepmc   +1 more source

GLP-1 receptor agonists-another promising therapy for Alport syndrome? [PDF]

J Rare Dis (Berlin)
Boeckhaus J, Mabillard H, Sayer JA.
europepmc   +1 more source

Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis. [PDF]

Clin Kidney J
Chalkia A, Jones R, Smith R, Willcocks L, Jayne D.   +4 more
europepmc   +1 more source

Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease. [PDF]

Nephrol Dial Transplant
Neuen BL, Yeung EK, Rangaswami J, Vaduganathan M.   +3 more
europepmc   +1 more source

Clinically available predictors of obstructive sleep apnoea requiring treatment in type 2 diabetes patients in primary care. [PDF]

Sci Rep
Agholme J, Ahtola K, Toll E, Carlhäll CJ, Henriksson P, Kechagias S, Lundberg P, Nasr P, Sysoev O, Wijkman M, Ekstedt M, Ulander M, Iredahl F.   +12 more
europepmc   +1 more source

Risk prediction modeling for cardiorenal clinical outcomes in patients with non-diabetic CKD using US nationwide real-world data. [PDF]

BMC Nephrol
Wanner C, Schuchhardt J, Bauer C, Brinker M, Kleinjung F, Vaitsiakhovich T.   +5 more
europepmc   +1 more source

Monocyte to high-density lipoprotein cholesterol ratio as a marker of the presence and progression of diabetic kidney disease. [PDF]

Ren Fail
Yang W, Zhong Y, Zhou P, Lu D.
europepmc   +1 more source

The prognostic value of remnant cholesterol to adverse renal outcomes in patients with type 2 diabetes. [PDF]

Diabetol Metab Syndr
Yu P, Yuan Q, Huang L, Tao L, Peng Z, Pu J.   +5 more
europepmc   +1 more source

Chronic kidney disease progression in patients with previous type 2 diabetes and/or hypertension: a population-based cohort study from primary care in Spain. [PDF]

BMJ Open
Cunillera-Puértolas O, Vizcaya D, Cobo-Guerrero S, Romano-Sánchez J, Bundó-Luque D, Arbiol-Roca A, Salvador-González B.   +6 more
europepmc   +1 more source